BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19833826)

  • 1. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
    Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
    Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
    Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
    Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
    Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
    Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-gene signature and clinical outcome in non-small-cell lung cancer.
    Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
    N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
    Sun Z; Wigle DA; Yang P
    J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.
    Hsu YC; Yuan S; Chen HY; Yu SL; Liu CH; Hsu PY; Wu G; Lin CH; Chang GC; Li KC; Yang PC
    Clin Cancer Res; 2009 Dec; 15(23):7309-15. PubMed ID: 19920108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
    Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
    Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
    Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; Misek DE; Chen G; Iannettoni MD; Orringer MB; Hanash S; Beer DG
    Clin Cancer Res; 2002 Dec; 8(12):3803-12. PubMed ID: 12473593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer.
    Petty RD; Kerr KM; Murray GI; Nicolson MC; Rooney PH; Bissett D; Collie-Duguid ES
    J Clin Oncol; 2006 Apr; 24(11):1729-44. PubMed ID: 16549823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
    Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
    Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.